Our UUO mouse model showed that a single injection of Nec-1 (inhibitor of RIPK1) ameliorated kidney injury, release of proinflammatory cytokines (IL-1β and TNF-α) and a chemokine (MCP-1), and renal fibrosis. Here, CCL2 is linked to renal fibrosis.